Zydus Cadila gets USFDA nod to market anti-dementia tablets

"Zydus Cadila has received final approval from the USFDA to market Memantine Hydrochloride tablets USP, 5mg and 10mg," Cadila Healthcare said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news